Cost-effectiveness of tumor necrosis factor-α antagonist in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Dean Andrew Regier, Nick Bansback, Anne Dar Santos, Carlo A. Marra*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of tumor necrosis factor-α antagonist in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences